MA19107A1 - Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . - Google Patents
Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one .Info
- Publication number
- MA19107A1 MA19107A1 MA19313A MA19313A MA19107A1 MA 19107 A1 MA19107 A1 MA 19107A1 MA 19313 A MA19313 A MA 19313A MA 19313 A MA19313 A MA 19313A MA 19107 A1 MA19107 A1 MA 19107A1
- Authority
- MA
- Morocco
- Prior art keywords
- piperidinylalkyl
- pyrido
- pyridine
- derivatives
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13484580A | 1980-03-28 | 1980-03-28 | |
US06/191,632 US4342870A (en) | 1980-03-28 | 1980-09-29 | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MA19107A1 true MA19107A1 (fr) | 1981-10-01 |
Family
ID=26832744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA19313A MA19107A1 (fr) | 1980-03-28 | 1981-03-21 | Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . |
Country Status (22)
Country | Link |
---|---|
US (1) | US4342870A (fr) |
EP (1) | EP0037265B1 (fr) |
AU (1) | AU537700B2 (fr) |
BG (1) | BG36199A3 (fr) |
CA (1) | CA1163994A (fr) |
CS (1) | CS256366B2 (fr) |
DE (1) | DE3168433D1 (fr) |
DK (1) | DK159390C (fr) |
ES (1) | ES500814A0 (fr) |
FI (1) | FI71737C (fr) |
GR (1) | GR72488B (fr) |
HU (1) | HU187329B (fr) |
IE (1) | IE51319B1 (fr) |
IL (1) | IL62494A (fr) |
MA (1) | MA19107A1 (fr) |
NO (1) | NO156752C (fr) |
NZ (1) | NZ196522A (fr) |
PH (1) | PH16530A (fr) |
PT (1) | PT72740B (fr) |
RO (1) | RO82508A (fr) |
SU (1) | SU1068037A3 (fr) |
YU (1) | YU43010B (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443451A (en) | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
EP0268309B1 (fr) * | 1986-09-22 | 1996-12-11 | Janssen Pharmaceutica N.V. | Antagonistes de la sérotonine pour le traitement des plaies |
IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
CA2000786C (fr) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
WO1990006303A1 (fr) * | 1988-12-02 | 1990-06-14 | Pfizer Inc. | Derives arylpiperidine |
EP0460118A1 (fr) * | 1989-03-23 | 1991-12-11 | Mallinckrodt International Corporation | Compose de piperidine marque a l'iode ou au brome radioactif, son procede de preparation et composition comprenant ledit compose |
DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
CA2129995C (fr) * | 1992-02-13 | 2000-04-11 | Albert A. Carr | Derives thiacycliques de piperidinyle |
EP0672043B1 (fr) * | 1992-07-13 | 2001-05-30 | Janssen Pharmaceutica N.V. | Nouveaux derives de 4-(3-benzofuranyl) piperidinyle et 4-(3-benzothienyle) piperidinyle et compositions pharmaceutiques les contenant |
ES2236700T3 (es) * | 1993-11-19 | 2005-07-16 | Janssen Pharmaceutica N.V. | 1,2-benzazoles microencapsulados. |
ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
AU2003288017A1 (en) * | 2002-11-13 | 2004-06-03 | Synthon B.V. | Process for making risperidone and intermediates therefor |
WO2004094414A1 (fr) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Sels hydrosolubles de risperidone |
ES2842289T3 (es) * | 2008-02-29 | 2021-07-13 | Vm Therapeutics Llc | Compuestos para tratar el síndrome del dolor y otros trastornos |
EA037123B1 (ru) | 2012-02-10 | 2021-02-09 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения спинальной мышечной атрофии |
JP6092264B2 (ja) | 2012-03-01 | 2017-03-08 | ピーティーシー セラピューティクス, インコーポレイテッド | 脊髄性筋委縮症を処置するための化合物 |
BR112014023483B1 (pt) | 2012-03-23 | 2022-05-10 | Ptc Therapeutics, Inc | Composto e seu uso, composição farmacêutica e seu uso |
WO2014143915A1 (fr) * | 2013-03-15 | 2014-09-18 | Vm Therapeutics Llc | Nouvelles formes cristallines |
WO2015105657A1 (fr) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Procédés pour moduler la quantité de transcrits d'arn |
EP4249472A3 (fr) | 2015-05-30 | 2023-12-13 | PTC Therapeutics, Inc. | Procédés de modulation de l'épissage de l'arn |
AU2016366694C1 (en) | 2015-12-10 | 2021-03-25 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
AU2017363369A1 (en) | 2016-11-28 | 2019-05-30 | Ptc Therapeutics, Inc | Methods for modulating RNA splicing |
KR20200033249A (ko) | 2017-06-05 | 2020-03-27 | 피티씨 테라퓨틱스, 인크. | 헌팅턴병 치료 화합물 |
US11608501B2 (en) | 2017-06-14 | 2023-03-21 | Ptc Therapeutics, Inc. | Methods for modifying RNA splicing |
MX2019015578A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
MX2019015580A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
JP7399870B2 (ja) | 2018-03-27 | 2023-12-18 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
DK3814357T3 (da) | 2018-06-27 | 2024-07-22 | Ptc Therapeutics Inc | Heterocykliske og heteroarylforbindelser til behandling af huntingtons sygdom |
EP3814360A1 (fr) | 2018-06-27 | 2021-05-05 | PTC Therapeutics, Inc. | Composés hétéroaryles pour le traitement de la maladie de huntington |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3412094A (en) * | 1967-06-21 | 1968-11-19 | Searle & Co | 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners |
US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
JPS5146497A (en) * | 1974-10-19 | 1976-04-20 | Masato Aiura | Hobuban |
JPS525795A (en) * | 1975-06-28 | 1977-01-17 | Sankyo Co Ltd | Preparation of tetrahydro pyridopyrimidinone derivatives |
HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
-
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/fr not_active Expired
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 BG BG8151433A patent/BG36199A3/xx unknown
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 EP EP81301335A patent/EP0037265B1/fr not_active Expired
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-28 RO RO81103848A patent/RO82508A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
PH16530A (en) | 1983-11-10 |
IE810706L (en) | 1981-09-28 |
AU537700B2 (en) | 1984-07-05 |
IL62494A0 (en) | 1981-05-20 |
AU6842981A (en) | 1981-10-01 |
ES8300763A1 (es) | 1982-11-01 |
PT72740B (en) | 1982-11-16 |
EP0037265A1 (fr) | 1981-10-07 |
SU1068037A3 (ru) | 1984-01-15 |
YU81081A (en) | 1983-12-31 |
NO156752C (no) | 1987-11-18 |
IE51319B1 (en) | 1986-12-10 |
CA1163994A (fr) | 1984-03-20 |
ES500814A0 (es) | 1982-11-01 |
US4342870A (en) | 1982-08-03 |
HU187329B (en) | 1985-12-28 |
YU43010B (en) | 1989-02-28 |
FI810956L (fi) | 1981-09-29 |
FI71737B (fi) | 1986-10-31 |
RO82508A (fr) | 1983-09-26 |
DK159390C (da) | 1991-03-04 |
FI71737C (fi) | 1987-02-09 |
DE3168433D1 (de) | 1985-03-07 |
CS256366B2 (en) | 1988-04-15 |
DK159390B (da) | 1990-10-08 |
BG36199A3 (en) | 1984-09-14 |
RO82508B (ro) | 1983-08-30 |
NO156752B (no) | 1987-08-10 |
IL62494A (en) | 1984-08-31 |
NZ196522A (en) | 1985-10-11 |
EP0037265B1 (fr) | 1985-01-23 |
GR72488B (fr) | 1983-11-14 |
PT72740A (en) | 1981-04-01 |
NO811058L (no) | 1981-09-29 |
DK138281A (da) | 1981-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA19107A1 (fr) | Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . | |
MX9203592A (es) | Derivados de sulfamoil-fenetilamina substituida. | |
ATE7657T1 (de) | 3-aryl-5-isothiazolderivate. | |
IT8120784A0 (it) | Imidazopiridine. | |
ES506783A0 (es) | Derivados de encefalina. | |
ATE33651T1 (de) | Imidazo(1,5-a)pyridin-derivate. | |
DE3682244D1 (de) | Substituierte dihydroimidazo(1,2-a)chinoxalinderivate. | |
DE3267918D1 (de) | Pyrazolo(3,4-b)pyridine derivatives | |
IT7924171A0 (it) | Imidazoliletossi-derivati di pirazol-aperta parentesi quadra 3,4-b chiusa parentesi quadra-piridin-5-metanoli. | |
FI811577L (fi) | Nya kinoxalin-1,4-dioxidderivat | |
FI874400A (fi) | Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat. | |
FI813757L (fi) | Nytt foerfarande foer framstaellning av imidazo/4,5-b/pyridiner och -pyrimidiner | |
NO884788L (no) | Nye rifamycin-derivater. | |
FI872073A (fi) | Derivat av propargyloxybenzener, deras framstaellning och fungicida sammansaettningar i vilka de ingaor. | |
BE886395A (fr) | Derives de rifamycine | |
DE3578177D1 (de) | 4,7-dihydropyrazolo(3,4-b)pyridin-derivate. | |
ATE11415T1 (de) | 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidi - 4-on-derivate. | |
AR229879A1 (es) | Procedimiento de preparacion de derivados de metil-quinoxalinil-1,4-dioxido | |
FI882389A0 (fi) | 5-substituerat-10-cyanmetylentieno/ 3,4-b/benzoazepin. | |
ES513538A0 (es) | Derivados de 24-ciclopropilcoleno-3 b,22-dioles. | |
FI810878L (fi) | Imidazo /4,5-b/ pyridinderivat anvaendbara som hjaertmedicin och dess framstaellning | |
FI854026A0 (fi) | 2-fenylpyrano/2,3-b/pyridiner. | |
MA19336A1 (fr) | Nouveaux derives organophosphonothioniques . | |
BE890893A (fr) | Derives de rifamycine | |
AR226749A1 (es) | Procedimiento de preparacion de derivados de 1,4-dioxido de 2-metilen-quinoxalina |